ECMO套管相关感染的欧洲多中心回顾性研究:特征与结局
该欧洲12个ICU多中心回顾性研究纳入109例ECMO套管相关感染(ECMO-CRI,定义为临床怀疑+套管部位细菌培养阳性)患者,其中78例合并同一病原体血培养阳性。病原体以肠杆菌科、凝固酶阴性葡萄球菌和肠球菌属为主,42%为混合感染。感染复发率13%,ICU死亡率51%。死亡危险因素为同一病原体血流感染和脓毒性休克。抗菌疗程≤8天与>8天相比,感染复发率和结局(包括死亡率)相似。
要点
- ECMO-CRI患者中78/109例(71.6%)合并同一病原体血流感染,42%为混合感染。
- ECMO-CRI的ICU死亡率为51%,感染复发率为13%。
- 死亡危险因素为同一病原体血流感染和脓毒性休克。
- 抗菌疗程≤8天与>8天相比,感染复发率和结局(包括死亡率)相似。
适用人群与场景
- 12个欧洲ICU中发生ECMO-CRI的患者,定义为临床怀疑加ECMO插管部位细菌培养阳性。
诊断标准与关键阈值
- ECMO-CRI定义:临床怀疑加ECMO插管部位细菌样本阳性。
红旗征与不能漏的情况
- 合并同一病原体血流感染和脓毒性休克为死亡危险因素。
研究设计与关键结果
- 多中心回顾性研究,纳入12个欧洲ICU的109例ECMO-CRI患者,其中78例合并同一病原体血培养阳性。
- 病原体以肠杆菌科、凝固酶阴性葡萄球菌和肠球菌属为主,42%为混合感染。
- 感染复发率13%,ICU死亡率51%。
- 死亡危险因素为同一病原体血流感染和脓毒性休克。
- 抗菌疗程≤8天与>8天相比,感染复发率和结局(包括死亡率)相似。
证据类型、等级与局限
- 研究类型:欧洲12个ICU多中心回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- ECMO-CRI常合并同一病原体血流感染且多为混合感染,临床需关注血培养结果。
- 对于ECMO-CRI,抗菌疗程≤8天似乎不增加复发或死亡风险,但原文为回顾性研究,作者结论为「似乎不相关」。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: Only few data regarding epidemiology and management of ECMO cannula-related infections (ECMO-CRIs) exist. The aim of our study was to describe their epidemiology and prognosis, and to evaluate factors associated with outcome.
METHODS: We performed a multicenter retrospective study in 12 European ICUs, including patients with ECMO-CRI, defined as a clinical suspicion plus a positive bacterial sample of ECMO-cannulation site. Primary objective was to describe ECMO-CRI characteristics and outcomes. Secondary objectives were to evaluate the rates of infection recurrence, their risk factors, and to evaluate the impact of antimicrobial treatment duration on outcome.
RESULTS: During the study period, 109 patients with ECMO-CRI (78 having concomitant positive blood culture with the same pathogen) were included. Pathogens responsible for infections were predominantly Enterobacteriaceae, coagulase-negative Staphylococcus and Enterococcus spp., and 42% of episodes were polymicrobial. Rates of infection recurrence was 13% and ICU-mortality rate was 51%. Risk factors for death were concomitant bloodstream infection with same pathogen and septic shock Patients with antibiotic course ≤ 8 days had similar infection recurrence rate and outcomes (including mortality) than patients with prolonged (> 8 days) antibiotic course.
CONCLUSION: ECMO-CRIs are frequently associated with BSI and frequently polymicrobial. Duration of antimicrobial treatment for ECMO-CRI ≤ 8 days does not seem to be associated with an increased risk of recurrence or death, as compared to longer treatment.
参考来源
- Ortuno S, Massart N, Vidal C, et al. Characteristics and outcomes of ECMO cannula-related infections: a European multicenter retrospective study. Ann Intensive Care. 2025. PMID: 40113722. doi:10.1186/s13613-025-01446-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。